Showing characteristics of our patient group
| Group A (SBL <10%) | Group B (SBL 10-25%) | Group (SBL 25-50%) | |
|---|---|---|---|
| Number | 8 | 10 | 5 |
| M:F | 8:0 | 4:6 | 2:3 |
| Median SBL in % | 5.2% | 18.45% | 38.4% |
| ICV intact | 2 | 3 | 4 |
| Colon | 5 intact 2 Partial | 8 intact 1 total 2 partial | 2 intact 1 total 2 partial |
| Bowel lengthening procedure | 2 | 3 | 0 |
| Enteral autonomy | 4 | 8 | 5 |
| Transplant | 2 | 1 | 0 |
| Complications | IFALD 1 Dla 1 | IFALD 1 Dla 4 | IFALD 0 Dla 1 |
| Duration of PN | 51.5 months | 46.4 months | 31.6months |
SBL – Small bowel length, IFALD- Intestinal failure associated liver disease, Dla – D lactic acidosis